Universal Health Services, Inc. (UHS) fair value analysis

S&P 500 · Updated 2026-09-07

Universal Health Services, Inc. is a healthcare company that operates a network of acute care hospitals and behavioral health facilities. The company provides inpatient and outpatient services across the United States and Puerto Rico.

Forward Fair Value verdict

Undervalued

Based on TickrTrends' weekly Forward Fair Value model, UHS is trading at more than a 25% discount to estimated fair value.

UHS currently ranks #25 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Undervalued for 3 consecutive weekly runs.

Last price: $169.65
Sector: Healthcare
12-month range: $144.69–$239.43

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: C
Momentum grade: A
Leverage: Moderate
Margin trend: Stable
Revenue growth: Modest
RSI zone: Neutral
52-week position: The lower-middle quarter of its range
DCF cross-check: Undervalued

What our data shows for UHS

Our model validated 17 trailing price-to-earnings windows for UHS, built from quarterly earnings records.
Shares are trading in the lower third of their 12-month price range of $144.69–$239.43.
The 14-day relative strength index sits at a neutral 47.
3 of the last 12 weekly snapshots showed positive price momentum.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for UHS
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent UHS news

TickrTrends' derived news-sentiment signal for UHS is currently leaning positive, computed from recent coverage.

Universal Health Services, Inc. (UHS) Q2 2026 Earnings Call Transcript (seekingalpha.com, 2026-07-28)
TickrTrends take: Universal Health Services operates in the Healthcare sector where TickrTrends currently assigns an Undervalued verdict to UHS stock. Q2 2026 earnings results provide an important opportunity to assess whether the company's operational performance and financial trajectory support this valuation assessment or suggest a need for revision. Valuation-focused investors should examine revenue trends, margin performance, and cash generation in the earnings call to determine if the undervaluation reflects a genuine opportunity or if market pricing has already adjusted since the valuation was established.

What people are saying

Follow the UHS conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — UHS moved into undervalued territory this week as TickrTrends' DCF cross-check band shifted from overvalued to undervalued, signaling improved relative value within the healthcare sector. The current valuation verdict reflects this positive repricing adjustment in the company's derived indicators.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is UHS stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), UHS is trading at more than a 25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.

What is UHS's TickrTrends verdict?

UHS's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.

How does UHS compare to other Healthcare stocks?

UHS ranks #25 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is UHS overbought or oversold?

UHS's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

UHS vs AVAH · UHS vs DXCM · UHS vs HQY · UHS vs HSTM · UHS vs IDXX